Quertle is creating a paradigm-shift in the way researchers approach the literature
Boulder, CO and Rockville, MD (PRWEB) June 2, 2010
Quertle, LLC and Ariadne announce a technology partnership to support new applications in biomedical text and knowledge search. Ariadne will provide both proprietary technology and technical resources to Quertle. In addition, Ariadne will package Quertle's semantic search engine as an appliance solution for the pharmaceutical and agricultural industry.
Quertle, a search engine for biomedical literature, uses cutting-edge, semantic-driven text analytics to find conceptual relationships scattered throughout a document. The technology not only uses query terms, but an innovative technology called Power Terms™ that represent entire classes of related concepts such as "diseases". It can automatically identify key concepts and provide the user with the most relevant literature and an intuitive way to explore it.
"Quertle is creating a paradigm-shift in the way researchers approach the literature," says Ilya Mazo, CEO of Ariadne, a leading provider of knowledge management solutions for the life sciences. "Rather than repackaging the same old methods, Quertle is the first biomedical search engine to focus on meaningful relationships. We are pleased to contribute to that revolution as well as have our own products benefit from their technologies."
The Quertle search engine will be enhanced by components of Ariadne's MedScan technology, a patent-pending series of algorithms that enable high-quality information and data retrieval from multiple sources of public information, text, journals and datasets. MedScan transform the extracted data into biological relationships, which supports a wide range of biological applications including Ariadne's Pathway Studio software product.
"The partnership enables Quertle to propel its search technologies and engine forward," said Jeffrey D. Saffer, President of Quertle. "By using Ariadne's MedScan technology, we can apply it to Quertle to refine and present relationships that are highly specific and correlated to the user's search term. As this partnership grows, we will continue to leverage the innovation from Ariadne to make Quertle the most dynamic and cutting-edge search tool available."
Ariadne (http://www.ariadnegenomics.com), a leader in bioinformatics, designs and develops software and knowledge integration solutions for pharmaceutical and life science researchers. Pathway Studio®, Ariadne's premier software product is an integrated database, supporting multiple omics profiling technologies, text mining, and experimental data analysis tools that provide an interactive scaffold for defining and testing in silico-based hypotheses across a wide range of disciplines.
Pathway Studio includes a family of ResNet® databases of biological relationships and curated pathways, both canonical and expert driven. The databases are powered by MedScan® technology, which researchers can use to edit and enhance database content from current literature and by adding proprietary data, experimental data from multiple omics profiling technologies and biological relationships, creating a unique and focused knowledgebase. A wide range of applications are supported including mechanistic modeling of disease, drug action and toxicity, as well as biomarker discovery, cellular and network pathway building, protein-protein interactions and much more. Pathway Studio is available in desktop and enterprise versions.
Quertle® (http://www.quertle.info) is a biomedical search engine focused on delivering informative results to biomedical researchers using advanced linguistic technologies, along with an in-depth understanding of the biomedical field.